Thomas Banaschewski, MD, Ph.D

Potential Conflict of Interest Disclosure in the last Year

 

  • Dr. Banaschewski has no stock ownership to disclose

 

  • Dr. Banaschewski has received CME support from from Eli Lilly, Ortho-McNeil/Janssen/Johnson and Johnson, Medice, Novartis, Shire, and UCB Pharmaceuticals

 

  • He is/has been involved in clinical trials for Eli Lilly and Shire

 

  • Dr. Banaschewski is/has been on the speakers’ bureau for Eli Lilly, Ortho-McNeil/Janssen/Johnson and Johnson, Medice, Novartis, Shire, and UCB Pharmaceuticals

 

  • He is/has been a consultant or on the advisory board for Eli Lilly, Medice, Novartis, Pfizer, Shire, and UCB Pharmaceuticals
Copyright 2008 by American Professional Society of ADHD and Related Disorders